Orchestra BioMed Holdings, Inc. Ordinary Shares
Symbol: OBIO (NASDAQ)
2.50
▲ (0.60%) 0.015
Company Description:
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Key Stats
- Today's Open: $2.47
- Today's High: $2.545
- Today's Low: $2.45
- Today's Volume: 73.49K
- Yesterday Close: $2.48
- Yesterday High: $2.53
- Yesterday Low: $2.4
- Yesterday Volume: 148.77K
- Last Min Volume: 40
- Last Min High: $2.495
- Last Min Low: $2.495
- Last Min VWAP: $2.495
Company Profile
- Name: Orchestra BioMed Holdings, Inc. Ordinary Shares
- Website: https://www.orchestrabiomed.com
- Listed Date: 2023-01-27
- Location: NEW HOPE, PA
- Market Status: Active
- CIK Number: 0001814114
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $133.81M
- Round Lot: 100
- Outstanding Shares: 53.96M
- Asset Type: CS
RECENT FILINGS FOR OBIO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-19 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-08 | 4 | View |
| 2025-08-08 | 4 | View |
| 2025-08-08 | 4 | View |
| 2025-08-08 | 4 | View |
| 2025-08-08 | 4 | View |
| 2025-08-08 | 4 | View |
| 2025-08-08 | 4 | View |
| 2025-08-08 | 4 | View |
| 2025-08-08 | 4 | View |
| 2025-08-08 | 4 | View |